StonvexLoading…
StonvexStonvexStonvexCore line items from HIPO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $468.60M | $372.10M | $209.70M | $119.70M |
Operating Income | $63.30M | $-27.40M | $-262.50M | $-325.20M |
Net Income | $57.70M | $-40.50M | $-273.10M | $-333.40M |
EPS (Diluted) | $2.22 | $-1.64 | $-11.58 | $-14.66 |
Total Assets | $1.91B | $1.54B | $1.52B | $1.57B |
Total Liabilities | $1.47B | $1.18B | $1.14B | $975.40M |
Cash & Equivalents | $218.30M | $197.60M | $142.10M | $194.50M |
Free Cash Flow OCF − CapEx | $9.10M | $47.20M | $-122.00M | $-166.40M |
Shares Outstanding | 25.70M | 24.87M | 24.15M | 23.20M |